Skip to content
healthcare.dev

Otezla

NDC 55513-137, apremilast, tablet, film coated, from Amgen, Inc.

Product NDC
55513-137
Status
Listed
Labeler
Amgen, Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205437
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-137 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • APREMILAST30 mg/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
55513-137-605551301376060 TABLET, FILM COATED in 1 BOTTLE (55513-137-60)
55513-137-95555130137951 BLISTER PACK in 1 CARTON (55513-137-95) / 28 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6b1f516-4972-4d82-bced-113e47b41cc5
  • NADAC price for package 55513013760

    GET /v1/drugs/nadac/55513013760

Use it

Look up 55513-137 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-137 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-137. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.